Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
Hetero gets WHO prequalification for generic Covid antiviral PaxlovidThis is the first WHO prequalification for Paxlovid - a combination of nirmatrelvir and ritonavir which is recommended for treating mild an...
Hetero gets DGCI approval for generic version of tocilizumab for treatment of Covid-19"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of To...
After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
Hetero launches FDC combination of key HIV drugsThe FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...
Delhi High Court asks Roche to explain lawsuit over Avastin copyRoche, which invented the drug and markets it under the blockbuster brand ‘Avastin’, has argued that Hetero’s drug is not a biosimilar to b...
Roche’s reputation at stake if Avastin biosimilar approved without trial: Kapil SibalThe judge asked the company to submit a compilation of judgments highlighting the protection given to drug innovators to support its call.
Post Invagen sale, Hetero says to strengthen US operationsCipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.
Cipla set to buy American business of Hetero Drugs for $550 millionPeople close to the transaction said Cipla will buy Invagen and Camber, Hetero’s wholly owned subsidiary, for about $550 million.
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent Pool
Hyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...
- Three cos bag Rs 92-lakh swine flu drug order
Ranbaxy Labs, Hetero Drugs and Strides Acrolabs have together bagged orders to supply 92-lakh capsules of generic or low-priced version of ...
- Hetero bags deal for 10 m Tamiflu
Hetero Drugs has pipped Ranbaxy Laboratories, Cipla, Natco Pharma, Strides Arcolabs and Roche India to bag half the government order to sup...
- Pharma companies donate tamiflu
The Indian arm of Swiss pharma major Hoffmann-La Roche and Hyderabad-based Hetero Drugs have together donated one lakh dosages of Tamiflu m...
- Hetero bags mega chunk of govt's anti-flu drug deal
Hyderabad-based Hetero Drugs has bagged the lion’s share of the government’s 10-million anti-flu drug order.
- Hetero Drugs close to receiving orders for its swine flu medicines
Hyderabad-based Hetero Drugs is close to receiving orders from foreign countries for its swine flu medicines worth at least $10 mn in the n...
- Delhi HC directs DCGI not to permit generic drugmakers for drugs already patented
The Delhi HC has directed the drug controller general of India to not give marketing or manufacturing permission to generic drug makers for...
- Hetero Drugs gets nod to produce 1% Nadifloxacin cream
In a relief to Hyderabad-based pharma company Hetero Drugs, the Supreme Court on Friday gave it the green signal to manufacture 1% Nadiflox...